talk-data.com talk-data.com

Topic

IaC

Infrastructure as Code (IaC)

cloud devops automation infrastructure_as_code

2

tagged

Activity Trend

6 peak/qtr
2020-Q1 2026-Q1

Activities

Showing filtered results

Filtering by: Databricks DATA + AI Summit 2023 ×
Rethinking Orchestration as Reconciliation: Software-Defined Assets in Dagster

This talk discusses “software-defined assets”, a declarative approach to orchestration and data management that makes it drastically easier to trust and evolve datasets and ML models. Dagster is an open source orchestrator built for maintaining software-defined assets.

In traditional data platforms, code and data are only loosely coupled. As a consequence, deploying changes to data feels dangerous, backfills are error-prone and irreversible, and it’s difficult to trust data, because you don’t know where it comes from or how it’s intended to be maintained. Each time you run a job that mutates a data asset, you add a new variable to account for when debugging problems.

Dagster proposes an alternative approach to data management that tightly couples data assets to code - each table or ML model corresponds to the function that’s responsible for generating it. This results in a “Data as Code” approach that mimics the “Infrastructure as Code” approach that’s central to modern DevOps. Your git repo becomes your source of truth on your data, so pushing data changes feels as safe as pushing code changes. Backfills become easy to reason about. You trust your data assets because you know how they’re computed and can reproduce them at any time. The role of the orchestrator is to ensure that physical assets in the data warehouse match the logical assets that are defined in code, so each job run is a step towards order.

Software-defined assets is a natural approach to orchestration for the modern data stack, in part because dbt models are a type of software-defined asset.

Attendees of this session will learn how to build and maintain lakehouses of software-defined assets with Dagster.

Connect with us: Website: https://databricks.com Facebook: https://www.facebook.com/databricksinc Twitter: https://twitter.com/databricks LinkedIn: https://www.linkedin.com/company/data... Instagram: https://www.instagram.com/databricksinc/

Turning Big Biology Data into Insights on Disease – The Power of Circulating Biomarkers

Profiling small molecules in human blood across global populations gives rise to a greater understanding of the varied biological pathways and processes that contribute to human health and diseases. Herein, we describe the development of a comprehensive Human Biology Database, derived from nontargeted molecular profiling of over 300,000 human blood samples from individuals across diverse backgrounds, demographics, geographical locations, lifestyles, diseases, and medication regimens, and its applications to inform drug development.

Approximately 11,000 circulating molecules have been captured and measured per sample using Sapient’s high-throughput, high-specificity rapid liquid chromatography-mass spectrometry (rLC-MS) platform. The samples come from cohorts with adjudicated clinical outcomes from prospective studies lasting 10-25 years, as well as data on individuals’ diet, nutrition, physical exercise, and mental health. Genetic information for a subset of subjects is also included and we have added microbiome sequencing data from over 150,000 human samples in diverse diseases.

An efficient data science environment is established to enable effective health insight mining across this vast database. Built on a customized AWS and Databricks “infrastructure-as-code” Terraform configuration, we employ streamlined data ETL and machine learning-based approaches for rapid rLC-MS data extraction. In mining the database, we have been able to identify circulating molecules potentially causal to disease; illuminate the impact of human exposures like diet and environment on disease development, aging, and mortality over decades of time; and support drug development efforts through identification of biomarkers of target engagement, pharmacodynamics, safety, efficacy, and more.

Connect with us: Website: https://databricks.com Facebook: https://www.facebook.com/databricksinc Twitter: https://twitter.com/databricks LinkedIn: https://www.linkedin.com/company/data... Instagram: https://www.instagram.com/databricksinc/